Skip to content
Home
About us
Co-founders
Our Team
Our Product Pipeline
Our Technology
Scientific Advisors
Investors
Science
AMD and Eyecyte-RPE
TM
Retinitis pigmentosa and Eyecyte-PRP
TM
AAV – mediated gene therapy
Publications
Resources
News and Media
Recognition
Collaborations
Research Alliance
Careers
Contact Us
Home
About us
Co-founders
Our Team
Our Product Pipeline
Our Technology
Scientific Advisors
Investors
Science
AMD and Eyecyte-RPE
TM
Retinitis pigmentosa and Eyecyte-PRP
TM
AAV – mediated gene therapy
Publications
Resources
News and Media
Recognition
Collaborations
Research Alliance
Careers
Contact Us
Eyestem Research announces immediate availability of its Anti-Covid Screening (ACS) platform using iPSC derived lung progenitors
Home
update
Eyestem Research announces immediate availability of its Anti-Covid Screening (ACS) platform using iPSC derived lung progenitors
Post Author:
eyetem@admin
Leave a Reply
Cancel reply
Your email address will not be published.
Comment
Name
Email
Website
Post navigation
Previous Post
Eyestem Research, India’s premier cell therapy company, announces successful completion of pre-IND meeting with FDA
Next Post
CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad & Eyestem Research Private Limited, Bangalore announce a unique public-private collaboration in the fight against Covid-19
